Last 19 quarters of trend data · Healthcare · Biotechnology
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.53 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 251.14 | 617.27 | 209.38 | 4439.58 | 70031.06 | 6212.87 | 11849.61 | 469.76 | 72239.57 | 3026.37 | 52991.22 | — | 79625.53 |
| — | -90.1% | -98.2% | +845.1% | -3.1% | +105.3% | -77.6% | — | -9.3% | — | — | — | — | |
| P/B Ratio | 13.96 | 0.86 | 0.64 | 1.47 | 132.24 | 44.36 | 121.34 | 9.86 | 518.70 | 53.07 | 125.71 | 327.24 | 70.34 |
| — | -98.1% | -99.5% | -85.1% | -74.5% | -16.4% | -3.5% | -97.0% | +637.4% | -82.3% | -57.0% | -91.0% | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | 69.87 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Cardio Diagnostics Holdings, Inc.'s operating margin was -59950.9% in Q3 2025, down 37493.3 pp QoQ and down 38538.0 pp YoY. The trailing four-quarter average of -72370.1% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin contracted 3137.9% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 100.0% | -3037.9% | -1092.5% | 100.0% | 100.0% | 100.0% | -418.2% | 100.0% | -1705.3% | 100.0% | 100.0% | — | 100.0% |
| — | -3137.9% | -161.2% | 0.0% | +105.9% | 0.0% | -518.2% | — | -1805.3% | — | — | — | 0.0% | |
| Operating Margin | -23977.9% | -59950.9% | -22457.5% | -173463.8% | -33608.2% | -21412.9% | -16295.6% | -26105.3% | -29039.5% | -14398.7% | -148008.2% | — | -250321.8% |
| — | -180.0% | -37.8% | -564.5% | -15.7% | -48.7% | +89.0% | — | +88.4% | — | — | — | -263.5% | |
| Net Margin | -24028.2% | -60053.8% | -22517.7% | -173943.0% | -33672.6% | -21467.6% | -16365.9% | -26140.0% | -26156.9% | -19266.0% | -233211.9% | — | -250321.8% |
| — | -179.7% | -37.6% | -565.4% | -28.7% | -11.4% | +93.0% | — | +89.6% | — | — | — | -1081.0% |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -134.0% | -19.2% | -16.0% | -15.6% | -22.9% | -41.8% | -42.2% | -138.9% | -53.0% | -74.4% | -127.1% | -26.7% | -34.3% |
| — | +54.1% | +62.2% | +88.8% | +56.7% | +43.8% | +66.8% | -419.5% | -54.5% | -522.8% | -691.0% | +14.9% | +2.0% | |
| ROA | -111.2% | -17.9% | -14.8% | -14.3% | -20.1% | -33.3% | -30.9% | -94.7% | -26.6% | -30.4% | -52.6% | -14.0% | -29.6% |
| — | +46.4% | +52.0% | +84.9% | +24.5% | -9.7% | +41.1% | -578.9% | +9.9% | -165.0% | -245.6% | +53.5% | +6.6% | |
| ROIC | -222.7% | -56.0% | -54.8% | -49.0% | -44.4% | -41.8% | -37.2% | -113.9% | -66.9% | — | — | — | -217.3% |
| — | -34.0% | -47.3% | +57.0% | +33.6% | — | — | — | +69.2% | — | — | — | -43.6% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has improved 104.3% YoY to 17.39x, strengthening the short-term liquidity position. Debt/Equity has risen for 3 consecutive quarters, indicating increasing financial leverage that investors should watch closely.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.10 | 0.06 | 0.06 | 0.05 | 0.10 | 0.20 | 0.28 | 0.35 | 0.43 | 0.82 | 0.31 | 0.09 | 0.20 |
| — | -69.5% | -80.2% | -84.8% | -76.2% | -76.0% | -10.0% | +281.3% | +116.0% | — | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 13.92 | 17.39 | 23.55 | 19.49 | 13.92 | 8.51 | 5.69 | 3.78 | 3.29 | 1.53 | 1.63 | 1.59 | 3.02 |
| — | +104.3% | +314.1% | +416.1% | +323.2% | +456.2% | +249.9% | +138.0% | +8.8% | -95.7% | -91.2% | -83.3% | -87.3% | |
| Quick Ratio | 13.92 | 17.39 | 23.55 | 19.49 | 13.92 | 8.51 | 5.69 | 3.78 | 3.29 | 1.53 | 1.63 | 1.59 | 3.02 |
| — | +104.3% | +314.1% | +416.1% | +323.2% | +456.2% | +249.9% | +138.0% | +8.8% | -95.7% | -91.2% | -83.3% | -87.3% | |
| Interest Coverage | -448.81 | -547.19 | -357.93 | -347.59 | -484.94 | -363.23 | -220.47 | -714.81 | -16.05 | -2.53 | -2.43 | -0.34 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 19 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonCardio Diagnostics Holdings, Inc.'s current P/E is -0.5x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Cardio Diagnostics Holdings, Inc.'s current operating margin is -23977.9%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Cardio Diagnostics Holdings, Inc.'s business trajectory between earnings reports.